Deals of the day-Mergers and acquisitions

(Adds J&J, Boston Scientific; updates Merck & Co) Jan 8 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1650 GMT on Monday: ** Johnson & Johnson JNJ.N said it had agreed to buy drug developer Ambrx Biopharma AMAM.O for $2 billion to gain access to drugs that belong to a class of targeted cancer therapies which have drawn interest from other drugmakers. urn:newsml:reuters.com:*:nL4N3DY280 ** Medical device maker Boston Scientific BSX.N said it had agreed to buy Axonics Inc AXNX.O for $3.7 billion, gaining access to devices used to improve bladder function. urn:newsml:reuters.com:*:nL4N3DY23G ** Merck & Co MRK.N said it would buy cancer drug developer Harpoon Therapeutics HARP.O for about $680 million, reinforcing its oncology portfolio with immunotherapies. urn:newsml:reuters.com:*:nL4N3DY27X ** The head of France's biggest supermarket chain E. Leclerc said it was still selling Pepsi after rival Carrefour CARR.PA ditched PepsiCo PEP.O products in the latest tug-of-war between retailers and global food giants over prices. urn:newsml:reuters.com:*:nL8N3DY1DK ** Malaysia's Capital A Berhad CAPI.KL said it intends to sell its aviation business to long-haul unit AirAsia X Bhd AIRX.KL , with a goal of consolidating both its long and short-haul operations under a single AirAsia brand. urn:newsml:reuters.com:*:nL4N3DY0RW (Compiled by Rajarshi Roy and Christy Santhosh in Bengaluru) (([email protected];))